| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df9fb8aaf1cd5064996ddd0de73b70fb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 |
| filingDate |
2020-07-24^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-12-20^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cec4efc3b4bbeae5864f209b971c5f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4586058f432f12543d0aa51e62f0ebc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f50fe61c37033a02c2e4f715772cb17f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2996fd8cfdca2bfee3c5f73331a3e274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fa27f1eb9f37cb62c0341ff397f604a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a16a79ea3eb17e3624258bcb7bc88f17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2de26b3215dae8ecbf376fe49d82b182 |
| publicationDate |
2022-12-20^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11530196-B2 |
| titleOfInvention |
Pyrimidine compound acting on EGFR and ERBB2 |
| abstract |
Disclosed is a pyrimidine compound acting on an EGFR exon 20 insertion mutation and an ERBB2 exon 20 insertion mutation or a pharmaceutically acceptable salt thereof. |
| priorityDate |
2019-07-26^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |